Benjamin J. Hindson net worth and biography

Benjamin Hindson Biography and Net Worth

Insider of 10x Genomics

Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, he was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad Laboratories in 2011. Before QuantaLife, Ben served in various positions of increasing responsibility at Lawrence Livermore National Laboratory in the Chemical and Biological Weapons Nonproliferation Program. He has published extensively in his field and holds numerous patents for assays and instrumentation. Ben earned his B.S. in Chemistry and his Ph.D in Chemistry from Deakin University, Australia.

What is Benjamin J. Hindson's net worth?: The estimated net worth of Benjamin J. Hindson is at least $9.72 million as of February 23rd, 2026. Dr. Hindson owns 424,779 shares of 10x Genomics stock worth more than $9,723,616 as of May 6th. This net worth estimate does not reflect any other assets that Dr. Hindson may own. Learn More about Benjamin J. Hindson's net worth.
How do I contact Benjamin J. Hindson?: The corporate mailing address for Dr. Hindson and other 10x Genomics executives is 6230 STONERIDGE MALL ROAD, PLEASANTON CA, 94588. 10x Genomics can also be reached via phone at 925-401-7300 and via email at [email protected]. Learn More on Benjamin J. Hindson's contact information.
Has Benjamin J. Hindson been buying or selling shares of 10x Genomics?: Benjamin J. Hindson has not been actively trading shares of 10x Genomics during the past quarter. Most recently, Benjamin J. Hindson sold 7,826 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $18.58, for a transaction totalling $145,407.08. Following the completion of the sale, the insider now directly owns 424,779 shares of the company's stock, valued at $7,892,393.82. Learn More on Benjamin J. Hindson's trading history.
Who are 10x Genomics' active insiders?: 10x Genomics' insider roster includes Bradford Crutchfield (Insider), Benjamin Hindson (Insider), Sridhar Kosaraju (Director), Mathai Mammen (Director), Alan Mateo (Director), Justin McAnear (CFO), Serge Saxonov (CEO), John Stuelpnagel (Director), Adam Taich (CFO), and James Wilbur (Insider). Learn More on 10x Genomics' active insiders.
Are insiders buying or selling shares of 10x Genomics?: During the last year, insiders at the sold shares 15 times. They sold a total of 139,879 shares worth more than $2,251,005.39. The most recent insider tranaction occured on April, 14th when CEO Serge Saxonov sold 5,000 shares worth more than $122,800.00. Insiders at 10x Genomics own 8.8% of the company. Learn More about insider trades at 10x Genomics.
Information on this page was last updated on 4/14/2026.

Benjamin J. Hindson Insider Trading History at 10x Genomics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/23/2026	Sell	7,826	$18.58	$145,407.08	424,779
11/24/2025	Sell	8,283	$19.00	$157,377.00	432,605
8/22/2025	Sell	7,486	$13.79	$103,231.94	440,888
5/22/2025	Sell	7,485	$8.30	$62,125.50	448,374
2/24/2025	Sell	4,573	$11.07	$50,623.11	335,324
8/22/2024	Sell	4,351	$22.53	$98,028.03	345,704
5/22/2024	Sell	4,087	$24.30	$99,314.10	350,055
2/22/2024	Sell	2,613	$46.34	$121,086.42	283,059
8/1/2023	Sell	6,970	$62.21	$433,603.70	284,236
7/19/2023	Sell	13,940	$60.03	$836,818.20	284,236
5/23/2023	Sell	2,388	$55.06	$131,483.28	284,236
2/22/2023	Sell	1,742	$47.75	$83,180.50	250,237
11/22/2022	Sell	2,361	$34.07	$80,439.27	217,713
8/23/2022	Sell	1,292	$35.19	$45,465.48	186,246
5/23/2022	Sell	1,264	$48.76	$61,632.64	187,538
2/22/2022	Sell	360	$78.59	$28,292.40
1/3/2022	Sell	41,666	$146.08	$6,086,569.28
12/1/2021	Sell	41,666	$148.08	$6,169,901.28
11/22/2021	Sell	351	$148.38	$52,081.38
11/1/2021	Sell	41,666	$163.58	$6,815,724.28
10/1/2021	Sell	41,666	$143.56	$5,981,570.96
9/1/2021	Sell	41,666	$177.50	$7,395,715.00
8/23/2021	Sell	337	$161.85	$54,543.45	47,117
5/24/2021	Sell	351	$162.66	$57,093.66
5/3/2021	Sell	41,666	$191.84	$7,993,205.44	60,716
4/1/2021	Sell	41,666	$184.54	$7,689,043.64	78,302
2/1/2021	Sell	33,750	$175.98	$5,939,325.00	69,686
1/4/2021	Sell	33,750	$139.93	$4,722,637.50	100,437
12/1/2020	Sell	33,750	$151.32	$5,107,050.00	101,250
11/2/2020	Sell	21,062	$136.38	$2,872,435.56	88,562
9/1/2020	Sell	27,692	$113.97	$3,156,057.24	95,192
8/3/2020	Sell	33,750	$99.34	$3,352,725.00	101,250
7/1/2020	Sell	33,750	$87.60	$2,956,500.00	101,250
6/1/2020	Sell	33,750	$79.85	$2,694,937.50	101,250
5/1/2020	Sell	33,750	$77.38	$2,611,575.00	101,250
4/1/2020	Sell	33,750	$58.12	$1,961,550.00	101,250
3/6/2020	Sell	33,750	$65.59	$2,213,662.50	101,250

Benjamin J. Hindson Buying and Selling Activity at 10x Genomics

10x Genomics Company Overview

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Today's Range

Now: $22.89

$21.88

$23.15

50 Day Range

MA: $21.38

$16.69

$26.08

2 Week Range

Now: $22.89

$7.72

$26.44

Volume

782,093 shs

Average Volume

2,567,120 shs

Market Capitalization

$2.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.05